Clinical features of PD-LRRK2 mutation carriers compared to mutation-negative index cases (i.e., no identified dominant or biallelic/monoallelic recessive variants in PD-related genes or GBA1) are presented in Table 2. This evidence concerns the gene GBA1 and Parkinson disease.